Crestor, a prescription medication primarily used to lower cholesterol levels in adults with a diagnosis of high cholesterol, is experiencing significant growth in the pharmaceutical market. One of the primary uses for this medication is in the treatment of high-fat diet and high-intensity exercise program conditions. It is commonly prescribed to individuals with type 2 diabetes and to those with a history of cardiovascular issues. In this article, we will delve into the various indications for its use, benefits, side effects, and important considerations for its approved uses,.
Rivaroxaban is an oral, selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) in the body. This inhibition results in the localilation of blood vessels and the release of nitric oxide. This process results in the improvements of blood vessels and the regulation of blood flow in the penis, which is crucial for the penile erection.
Crestor is primarily used in the treatment of symptomatic benign prostatic hyperplasia (BPH), which is a urinary and sexual disorder characterized by the overproduction of urine by the prostate gland. This excess of urine causes acute urinary retention, leading to acute and chronic obstructive pulmonary disease (BPH-BOR).
Crestor is prescribed for the treatment of BPH, particularly for patients who have not responded to conservative measures. It is also commonly used to manage symptomatic and asymptomatic symptomatic pulmonary arterial hypertension (PAH), in patients with symptomatic BPH without evidence of pulmonary arterial hypertension.
The most commonly reported side effects of Crestor (Rosuvastatin) use are headache, back pain, dyspepsia, nasal congestion, and flushing. These side effects are generally mild and subside as the body adjusts to the medication. However, they are more likely to occur at a slower rate than during a standard dose.
It is important to note that the risk of experiencing these side effects is considered low when taken as prescribed, and it is not increased by diet or exercise.
It is essential to inform healthcare providers about any medications being taken, including over-the-counter and prescription medications, to minimize the risk of adverse effects.
Some individuals may experience adverse effects due to the interaction of Crestor with specific medications. For instance, an increase in blood pressure or loss of vision in one of the affected eyes has been observed in subjects who took Crestor for 4 weeks. These eye effects were attributed to Crestor having a higher concentration in the blood vessels in the eye, the mechanism of which is not clearly understood.
Other reported adverse effects of Crestor (Rosuvastatin) use include flushing, dizziness, headache, and blurred vision. Flushing has also been reported with Crestor (Rosuvastatin) use, with the most commonly reported adverse effects occurring in the lower third of the body.
It is essential to inform healthcare providers about any herbal products, nasal sprays, nasal corticosteroids, or oral contraceptive medications being taken, to minimize the risk of adverse effects.
Crestor (Rosuvastatin) is often prescribed in the setting of a low-intensity exercise program to aid in the treatment of symptomatic benign prostatic hyperplasia (BPH). As a result, individuals may be able to minimize the risk of adverse effects.
Crestor (Rosuvastatin) is indicated for the treatment of BPH, particularly for individuals with BPH-related symptoms. It is commonly prescribed for the treatment of symptomatic BPH, as well as the management of symptomatic PAH. It has also been prescribed off-label for the treatment of symptomatic PAH. However, the use of Crestor (Rosuvastatin) in these conditions requires careful consideration of its specific indications, risks, and considerations.
Crestor (Rosuvastatin) belongs to the class of medications called calcium-channel blockers (CCBs). It works by preventing the influx of calcium ions into the cell, which leads to the relaxation of smooth muscle in the vascular smooth muscle and increased blood flow.
Product name:Crestor (Rosuvastatin) 10mg/5mg
Company name:
DIN:007221727
Status:Marketed
Status date:2007-11-05
| Active ingredient(s) | Strength |
|---|---|
| Rosuvastatin | 10mg |
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers| Resource | Description |
|---|---|
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections:
| |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$14.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Stomach Healthylife :30 tabletsHealthylife.com.au is a reliable source for products for everyone's use. We have been providing customer service to Bazaarvoice.au for years. When your product isn't in use, Healthylife.com.au may not be where you need it. Healthylife.com.au offers several important tips about purchasing only safe, legitimate products. Please review the products' information carefully before you can purchase any. Bazaarvoice.au provides information about safe and legitimate products, which will assist you in making an informed purchasing decision. Please complete your country of Origin and search for 'crestor' for cvs. Healthylife.com.au. products listed on the Bazaarvoice.au.nz website for CVS and other pharmacy chains. products listed on the Bazaarvoice.au.nz website for bbq. Healthylife.com.au provides information about safe and legitimate products, which will assist you in making an informed purchasing decision. Please complete the country of Origin and search for 'crestor' for bbq.
In a statement, AstraZeneca said that the company has received "some very encouraging" recent information from a recent review by the U. S. Food and Drug Administration. "We are extremely pleased with this announcement," the company said.
The U. Food and Drug Administration issued a safety alert for the generic form of Crestor in June 2010. The agency cited the manufacturer's recent release of a recent warning on Crestor's market, which states: "This product has the potential for significant adverse events, including cardiovascular events and death, that are similar to those reported with the other (sustained release) Crestor."
Food and Drug Administration said that it has not received any reports of serious adverse events or adverse event related to Crestor in the past 30 days.
In October 2011, AstraZeneca said that it was conducting a review of Crestor's safety information. It is not clear how the review will impact the company or the information presented. It also is not clear whether the review is being conducted for AstraZeneca or if there are other similar products in the same market, or whether other companies have similar products in the same market.
In October 2011, AstraZeneca said that it had received two studies of Crestor's safety in the United States. The second one was from Canada and the third was from the Netherlands.
AstraZeneca said that it has been informed of the safety of Crestor. It said that the company has received information from several Canadian and American studies indicating Crestor may have a higher risk of cardiovascular side effects.
The company has also received from the U. Food and Drug Administration and several European countries that Crestor has not been approved for sale or marketing in the U.
AstraZeneca said that it is currently conducting a clinical trial and that the company will continue to review the safety of Crestor to determine its suitability for patients.
In October 2011, a company spokesman said that Crestor is not approved for sale or marketing in the U.
AstraZeneca said that it has received three studies of Crestor and that the company would continue to monitor the company's progress and determine whether Crestor's safety is still being evaluated.
AstraZeneca said that it has received more than two reports of serious adverse events or adverse event related to Crestor in the U.
In December 2011, AstraZeneca said that a number of other products that have been discontinued or have been withdrawn have been marketed for the treatment of heart conditions.
In December 2011, AstraZeneca said that it had received three reports of adverse events or adverse event related to Crestor in the United States. The company also received a number of reports of adverse events or adverse event related to Crestor in the U.
AstraZeneca said that it has received a number of reports of serious adverse events or adverse event related to Crestor in the U. and that the company will continue to monitor the company's progress and determine whether Crestor's safety is still being evaluated.
AstraZeneca said that the company is committed to providing a safe and effective treatment for patients.
AstraZeneca said that it will be discontinuing the drug in the U. and will not discontinue the Crestor product until further information is available. The company said it will be reviewing the safety and efficacy data from the clinical trials. The company is reviewing the safety and efficacy data from the clinical trials.AstraZeneca said that it has completed a review of the Crestor product to determine whether the manufacturer is still considering the FDA approval of Crestor.In February 2012, AstraZeneca said it was conducting a clinical trial to determine whether Crestor is safe and effective in patients with certain heart conditions.
In March 2012, AstraZeneca said that it is reviewing a number of Crestor studies to determine the safety of Crestor for patients with certain heart conditions.
Crestor (rosuvastatin) is the brand name for the medicine CRESTOR manufactured by Astra Zeneca. CRESTOR is used for the treatment of heart failure, high blood pressure (hypertension), cholesterol disorders (e.g., heart failure, mixed dyslipidemia), and non-alcoholic fatty liver disease. CRESTOR belongs to a group of medicines called statins.
The active substance in CRESTOR is rosuvastatin. CRESTOR is used alone or with other medicines to treat high blood pressure (hypertension), to lower cholesterol (cholesterol), to treat non-alcoholic fatty liver disease (e.g., mixed dyslipidemia), and to prevent the development of gallstones (a condition in which the liver produces too much of a mineralocin). It is also used in the treatment of cholesterol-related eye diseases (such as macular degeneration). CRESTOR is a very safe and well tolerated medicine. CRESTOR is a very safe medicine. It is also a very safe medicine that is used alone or in conjunction with other medicines to treat heart failure, high blood pressure (hypertension), cholesterol disorders (e.g., heart failure, mixed dyslipidemia), to lower cholesterol (cholesterol), to treat non-alcoholic fatty liver disease (e.g., mixed dyslipidemia), and to prevent the development of gallstones (a condition in which the liver produces too much of a mineralocin). It is also a very safe medicine that is used in the treatment of cholesterol-related eye diseases (such as macular degeneration).
Stade de France Pharmacy